Abstract:BACKGROUND:Both hyperglycaemia and dendritic cells (DCs) play causative roles in atherosclerosis. However, whether they interact in atherosclerosis remains uncertain. Therefore, we examined whether high glucose could regulate the expression of scavenger receptors responsible for oxidised low-density lipoprotein (oxLDL) uptake in DCs, a critical step in atherogenesis. In addition, we investigated the impact of glucose on DC maturation regarding changes in phenotype and cytokine secretion.METHODS:Immature DCs were cultured with different concentrations of glucose (5.5 mmol/L, 15 mmol/L, 30 mmol/L) in the absence or presence of N-acetylcysteine (NAC), SB203580 or Bay11-7082 for 24 hours. We used 30 mmol/L mannitol as a high-osmolarity control treatment. The expression of the scavenger receptors SR-A, CD36 and LOX-1 was determined by real-time PCR and western blot analysis. Furthermore, DCs were incubated with DiI-labelled oxLDL. The DiI-oxLDL-incorporated fraction was investigated by flow cytometry analysis. The intracellular production of ROS in DCs was measured by dichlorodihydrofluorescein (DCF) fluorescence using confocal microscopy. Finally, flow cytometry analysis was used to investigate immunophenotypic protein expression (CD83 and CD86). Supernatant cytokine measurements were used for immune function assays.RESULTS:The incubation of DCs with glucose enhanced, in a dose-dependent manner, the gene and protein expression of SR-A, CD36 and LOX-1. This effect was partially abolished by NAC, SB203580 and Bay11-7082. Incubation of DCs with mannitol (30 mmol/L) did not enhance these scavenger receptors' expression. High glucose upregulated the production of ROS and expression of p38 MAPK in DCs. NAC partially reversed p38 MAPK upregulation. High glucose increased the oxLDL-uptake capacity of DCs. Blockage of the scavenger receptors SR-A and CD36 reduced oxLDL uptake, but blockage of LOX-1 did not. Furthermore, high-glucose (15 mmol/L or 30 mmol/L) treatment increased CD86 and CD83 in DCs. High glucose also increased IL-6 and IL-12 secretion and decreased IL-10 secretion.CONCLUSION:High glucose can increase the expression of the scavenger receptors SR-A, CD36 and LOX-1, which can increase the oxLDL-uptake capacity of DCs. High glucose induces a proinflammatory cytokine profile in human DCs, leading to DC maturation. These results support the hypothesis that atherosclerosis is aggravated by hyperglycaemia-induced DC activation and oxLDL uptake.

Abstract 5523: High Glucose Promotes Intracellular Lipid Accumulation by Impairing the Balance Between CD36 and ATP-Binding Cassette Transporter G1 in Vascular Smooth Muscle Cells

High glucose promotes intracellular lipid accumulation in vascular smooth muscle cells by impairing cholesterol influx and efflux balance.

High Glucose Decreases the Expression of ATP-binding Cassette Transporter G1 in Human Vascular Smooth Muscle Cells

High Glucose Induces the Expression of CD36 in Vascular Smooth Muscular Cells

Multi-omics analysis identifies potential mechanisms by which high glucose accelerates macrophage foaming

Effect of high glucose on the expression of liver X receptors and ABCA1 in human THP-1 macrophages

[High glucose suppresses ABCG1 expression by increasing oxidative stress and inducing nuclear factor-kappaB activation in vascular smooth muscle cells].

Endothelial Dysfunction Induced by High Glucose is Associated with Decreased ATP-binding Cassette Transporter G1 Expression

Intracellular-free calcium dynamics and F-actin alteration in the formation of macrophage foam cells.

Effect of high glucose on expression and function of ABC transporters in THP-1 monocyte-derived macrophages

High Glucose Induces Upregulation of Scavenger Receptors and Promotes Maturation of Dendritic Cells

ATP-binding Cassette Transporter G1 Protects Against Endothelial Dysfunction Induced by High Glucose

Integrated multi-omic high-throughput strategies across-species identified potential key diagnostic, prognostic, and therapeutic targets for atherosclerosis under high glucose conditions

CML/CD36 Accelerates Atherosclerotic Progression Via Inhibiting Foam Cell Migration

Imbalanced Response of ATP-binding Cassette Transporter A1 and CD36 Expression to Increased Oxidized Low-Density Lipoprotein Loading Contributes to the Development of THP-1 Derived Foam Cells.

Advanced Glycation End Products Induce Vascular Smooth Muscle Cell-Derived Foam Cell Formation and Transdifferentiate to a Macrophage-Like State.

Identification of candidate biomarkers and mechanisms in foam cell formation from heterogeneous cellular origins via integrated transcriptome analysis

Nε-Carboxymethyl-Lysine Negatively Regulates Foam Cell Migration Via the Vav1/Rac1 Pathway

High glucose up-regulates lipopolysaccharide-stimulated inflammatory cytokine production via c-jun N-terminal kinase in the monocytic cell line THP-1

Enhancement of lipopolysaccharide-induced toll-like receptor 2 expression and inflammatory cytokine secretion in HUVECs under high glucose conditions